nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitoxantrone—Urine abnormality—Varenicline—nicotine dependence	0.0398	0.0496	CcSEcCtD
Mitoxantrone—Urine analysis abnormal—Varenicline—nicotine dependence	0.0375	0.0467	CcSEcCtD
Mitoxantrone—Platelet count decreased—Varenicline—nicotine dependence	0.0371	0.0462	CcSEcCtD
Mitoxantrone—Electrocardiogram abnormal—Varenicline—nicotine dependence	0.0337	0.0419	CcSEcCtD
Mitoxantrone—Menstrual disorder—Varenicline—nicotine dependence	0.0324	0.0403	CcSEcCtD
Mitoxantrone—Menorrhagia—Varenicline—nicotine dependence	0.0298	0.0371	CcSEcCtD
Mitoxantrone—PIM1—cardiovascular system—nicotine dependence	0.0286	0.176	CbGeAlD
Mitoxantrone—Fungal infection—Varenicline—nicotine dependence	0.0286	0.0356	CcSEcCtD
Mitoxantrone—Viral infection—Varenicline—nicotine dependence	0.0244	0.0304	CcSEcCtD
Mitoxantrone—PIM1—midbrain—nicotine dependence	0.0223	0.137	CbGeAlD
Mitoxantrone—Hyperkalaemia—Varenicline—nicotine dependence	0.0217	0.027	CcSEcCtD
Mitoxantrone—SLC47A2—brain—nicotine dependence	0.0215	0.132	CbGeAlD
Mitoxantrone—Renal failure acute—Varenicline—nicotine dependence	0.0173	0.0216	CcSEcCtD
Mitoxantrone—BTK—brain—nicotine dependence	0.0162	0.0996	CbGeAlD
Mitoxantrone—Gastrointestinal haemorrhage—Varenicline—nicotine dependence	0.016	0.0199	CcSEcCtD
Mitoxantrone—Abdominal pain upper—Varenicline—nicotine dependence	0.0146	0.0182	CcSEcCtD
Mitoxantrone—Hypokalaemia—Varenicline—nicotine dependence	0.0146	0.0181	CcSEcCtD
Mitoxantrone—PIM1—brain—nicotine dependence	0.014	0.0863	CbGeAlD
Mitoxantrone—Erectile dysfunction—Varenicline—nicotine dependence	0.0127	0.0159	CcSEcCtD
Mitoxantrone—Weight increased—Varenicline—nicotine dependence	0.0126	0.0157	CcSEcCtD
Mitoxantrone—Hyperglycaemia—Varenicline—nicotine dependence	0.0125	0.0155	CcSEcCtD
Mitoxantrone—Acute coronary syndrome—Varenicline—nicotine dependence	0.0122	0.0151	CcSEcCtD
Mitoxantrone—Myocardial infarction—Varenicline—nicotine dependence	0.0121	0.0151	CcSEcCtD
Mitoxantrone—Stomatitis—Varenicline—nicotine dependence	0.012	0.015	CcSEcCtD
Mitoxantrone—Conjunctivitis—Varenicline—nicotine dependence	0.012	0.0149	CcSEcCtD
Mitoxantrone—Sinusitis—Varenicline—nicotine dependence	0.0116	0.0144	CcSEcCtD
Mitoxantrone—Bradycardia—Varenicline—nicotine dependence	0.0113	0.014	CcSEcCtD
Mitoxantrone—CYP1B1—cardiovascular system—nicotine dependence	0.0112	0.0691	CbGeAlD
Mitoxantrone—Chills—Varenicline—nicotine dependence	0.00994	0.0124	CcSEcCtD
Mitoxantrone—Arrhythmia—Varenicline—nicotine dependence	0.0099	0.0123	CcSEcCtD
Mitoxantrone—Erythema—Varenicline—nicotine dependence	0.00964	0.012	CcSEcCtD
Mitoxantrone—Dysgeusia—Varenicline—nicotine dependence	0.00944	0.0118	CcSEcCtD
Mitoxantrone—Back pain—Varenicline—nicotine dependence	0.00933	0.0116	CcSEcCtD
Mitoxantrone—Vision blurred—Varenicline—nicotine dependence	0.00909	0.0113	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Varenicline—nicotine dependence	0.00895	0.0111	CcSEcCtD
Mitoxantrone—Anaemia—Varenicline—nicotine dependence	0.00891	0.0111	CcSEcCtD
Mitoxantrone—Malaise—Varenicline—nicotine dependence	0.0087	0.0108	CcSEcCtD
Mitoxantrone—Cough—Varenicline—nicotine dependence	0.00842	0.0105	CcSEcCtD
Mitoxantrone—Convulsion—Varenicline—nicotine dependence	0.00836	0.0104	CcSEcCtD
Mitoxantrone—Hypertension—Varenicline—nicotine dependence	0.00833	0.0104	CcSEcCtD
Mitoxantrone—Chest pain—Varenicline—nicotine dependence	0.00821	0.0102	CcSEcCtD
Mitoxantrone—Myalgia—Varenicline—nicotine dependence	0.00821	0.0102	CcSEcCtD
Mitoxantrone—Arthralgia—Varenicline—nicotine dependence	0.00821	0.0102	CcSEcCtD
Mitoxantrone—Anxiety—Varenicline—nicotine dependence	0.00818	0.0102	CcSEcCtD
Mitoxantrone—Discomfort—Varenicline—nicotine dependence	0.00811	0.0101	CcSEcCtD
Mitoxantrone—Oedema—Varenicline—nicotine dependence	0.00787	0.0098	CcSEcCtD
Mitoxantrone—Infection—Varenicline—nicotine dependence	0.00782	0.00973	CcSEcCtD
Mitoxantrone—Shock—Varenicline—nicotine dependence	0.00774	0.00964	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Varenicline—nicotine dependence	0.00771	0.00959	CcSEcCtD
Mitoxantrone—Tachycardia—Varenicline—nicotine dependence	0.00768	0.00956	CcSEcCtD
Mitoxantrone—Skin disorder—Varenicline—nicotine dependence	0.00765	0.00951	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Varenicline—nicotine dependence	0.00761	0.00947	CcSEcCtD
Mitoxantrone—SLC47A1—brain—nicotine dependence	0.00752	0.0462	CbGeAlD
Mitoxantrone—Anorexia—Varenicline—nicotine dependence	0.0075	0.00934	CcSEcCtD
Mitoxantrone—Hypotension—Varenicline—nicotine dependence	0.00736	0.00915	CcSEcCtD
Mitoxantrone—CYP2E1—cardiovascular system—nicotine dependence	0.00724	0.0445	CbGeAlD
Mitoxantrone—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00717	0.00892	CcSEcCtD
Mitoxantrone—Dyspnoea—Varenicline—nicotine dependence	0.00702	0.00873	CcSEcCtD
Mitoxantrone—Somnolence—Varenicline—nicotine dependence	0.007	0.00871	CcSEcCtD
Mitoxantrone—Dyspepsia—Varenicline—nicotine dependence	0.00693	0.00862	CcSEcCtD
Mitoxantrone—Decreased appetite—Varenicline—nicotine dependence	0.00684	0.00852	CcSEcCtD
Mitoxantrone—Fatigue—Varenicline—nicotine dependence	0.00679	0.00845	CcSEcCtD
Mitoxantrone—Pain—Varenicline—nicotine dependence	0.00673	0.00838	CcSEcCtD
Mitoxantrone—Constipation—Varenicline—nicotine dependence	0.00673	0.00838	CcSEcCtD
Mitoxantrone—ABCG2—midbrain—nicotine dependence	0.00653	0.0402	CbGeAlD
Mitoxantrone—Feeling abnormal—Varenicline—nicotine dependence	0.00649	0.00807	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Varenicline—nicotine dependence	0.00644	0.00801	CcSEcCtD
Mitoxantrone—Urticaria—Varenicline—nicotine dependence	0.00625	0.00778	CcSEcCtD
Mitoxantrone—Body temperature increased—Varenicline—nicotine dependence	0.00622	0.00774	CcSEcCtD
Mitoxantrone—Abdominal pain—Varenicline—nicotine dependence	0.00622	0.00774	CcSEcCtD
Mitoxantrone—Hypersensitivity—Varenicline—nicotine dependence	0.0058	0.00722	CcSEcCtD
Mitoxantrone—Asthenia—Varenicline—nicotine dependence	0.00565	0.00703	CcSEcCtD
Mitoxantrone—CYP1B1—brain—nicotine dependence	0.00551	0.0339	CbGeAlD
Mitoxantrone—Diarrhoea—Varenicline—nicotine dependence	0.00539	0.0067	CcSEcCtD
Mitoxantrone—Vomiting—Varenicline—nicotine dependence	0.005	0.00623	CcSEcCtD
Mitoxantrone—Rash—Varenicline—nicotine dependence	0.00496	0.00618	CcSEcCtD
Mitoxantrone—Dermatitis—Varenicline—nicotine dependence	0.00496	0.00617	CcSEcCtD
Mitoxantrone—ABCC1—brain—nicotine dependence	0.00496	0.0305	CbGeAlD
Mitoxantrone—Headache—Varenicline—nicotine dependence	0.00493	0.00614	CcSEcCtD
Mitoxantrone—Nausea—Varenicline—nicotine dependence	0.00468	0.00582	CcSEcCtD
Mitoxantrone—ABCB1—cardiovascular system—nicotine dependence	0.00412	0.0254	CbGeAlD
Mitoxantrone—ABCG2—brain—nicotine dependence	0.0041	0.0252	CbGeAlD
Mitoxantrone—CYP2E1—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00381	0.113	CbGpPWpGaD
Mitoxantrone—CYP2E1—brain—nicotine dependence	0.00355	0.0218	CbGeAlD
Mitoxantrone—ABCB1—midbrain—nicotine dependence	0.00322	0.0198	CbGeAlD
Mitoxantrone—BTK—Regulation of actin dynamics for phagocytic cup formation—WASF2—nicotine dependence	0.00272	0.0805	CbGpPWpGaD
Mitoxantrone—BTK—Regulation of actin dynamics for phagocytic cup formation—WASF1—nicotine dependence	0.00261	0.0772	CbGpPWpGaD
Mitoxantrone—CYP2E1—Xenobiotics—CYP2A7—nicotine dependence	0.00236	0.0698	CbGpPWpGaD
Mitoxantrone—BTK—Fcgamma receptor (FCGR) dependent phagocytosis—WASF2—nicotine dependence	0.00206	0.0608	CbGpPWpGaD
Mitoxantrone—ABCB1—brain—nicotine dependence	0.00202	0.0124	CbGeAlD
Mitoxantrone—BTK—Fcgamma receptor (FCGR) dependent phagocytosis—WASF1—nicotine dependence	0.00197	0.0583	CbGpPWpGaD
Mitoxantrone—CYP1B1—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.0015	0.0444	CbGpPWpGaD
Mitoxantrone—CYP1B1—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00148	0.0438	CbGpPWpGaD
Mitoxantrone—CYP1B1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00122	0.036	CbGpPWpGaD
Mitoxantrone—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.0011	0.0324	CbGpPWpGaD
Mitoxantrone—SLC47A2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00101	0.0297	CbGpPWpGaD
Mitoxantrone—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000981	0.029	CbGpPWpGaD
Mitoxantrone—CYP2E1—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000968	0.0286	CbGpPWpGaD
Mitoxantrone—CYP2E1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000795	0.0235	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000686	0.0203	CbGpPWpGaD
Mitoxantrone—SLC47A1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000648	0.0192	CbGpPWpGaD
Mitoxantrone—CYP1B1—Biological oxidations—CYP2A7—nicotine dependence	0.000647	0.0191	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000638	0.0188	CbGpPWpGaD
Mitoxantrone—TOP2A—Circadian rythm related genes—CHRNB2—nicotine dependence	0.000545	0.0161	CbGpPWpGaD
Mitoxantrone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000455	0.0134	CbGpPWpGaD
Mitoxantrone—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000449	0.0133	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000448	0.0132	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—WASF2—nicotine dependence	0.000427	0.0126	CbGpPWpGaD
Mitoxantrone—CYP2E1—Biological oxidations—CYP2A7—nicotine dependence	0.000422	0.0125	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000417	0.0123	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—WASF1—nicotine dependence	0.00041	0.0121	CbGpPWpGaD
Mitoxantrone—TOP2A—Circadian rythm related genes—DRD2—nicotine dependence	0.000403	0.0119	CbGpPWpGaD
Mitoxantrone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000369	0.0109	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—WASF2—nicotine dependence	0.000249	0.00736	CbGpPWpGaD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000244	0.00721	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—WASF1—nicotine dependence	0.000239	0.00705	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000215	0.00635	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000208	0.00614	CbGpPWpGaD
Mitoxantrone—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000196	0.00579	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000193	0.00571	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—AKR1B10—nicotine dependence	0.000147	0.00434	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000116	0.00343	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CYP2A7—nicotine dependence	0.000114	0.00338	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CYP2A7—nicotine dependence	0.000111	0.00327	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CYP2A7—nicotine dependence	0.000101	0.00297	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CYP2A7—nicotine dependence	7.22e-05	0.00213	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CYP2A7—nicotine dependence	5.44e-05	0.00161	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CYP2A7—nicotine dependence	3.35e-05	0.00099	CbGpPWpGaD
